The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Exosome Diagnostic And Therapeutic Market Projected To Reach By 2030?
The exosome diagnostic and therapeutic market has experienced substantial expansion in recent years. This market is projected to expand from $0.6 billion in 2025 to $0.77 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 28.0%. The historical increase can be attributed to several factors, including developments in molecular biology research, rising investment in regenerative medicine, increased academic research focusing on extracellular vesicles, the expansion of biotech research infrastructure, and the growing availability of exosome analysis tools.
The exosome diagnostic and therapeutic market is anticipated to experience substantial growth in the upcoming years. It is predicted to expand to $2.07 billion by 2030, driven by a compound annual growth rate (CAGR) of 28.0%. This forecasted expansion is attributable to factors such as the increasing clinical application of exosome therapies, a heightened demand for personalized medicine solutions, the broadening of AI-enabled exosome data analysis, growing pharmaceutical engagement in biologic delivery systems, and enhanced regulatory clarity for advanced therapies. Prominent trends expected during this forecast period include the expanding use of exosomes for targeted drug delivery, a rising acceptance of liquid biopsy diagnostics, an increasing requirement for regenerative medicine applications, the development of advanced exosome isolation technologies, and a stronger emphasis on precision therapeutic development.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12346&type=smp
Which Factors Are Influencing The Growth Of The Exosome Diagnostic And Therapeutic Market?
An increasing incidence of chronic illnesses is anticipated to fuel the expansion of the exosome diagnostic and therapeutic market. Chronic disease refers to conditions lasting three months or more, which can deteriorate over time. Exosomes, when applied in diagnostics and therapeutics, act as potential biomarkers in cancer, enabling more sensitive disease monitoring and making personalized medicine more accessible. For instance, in January 2023, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, reported a projection of 142.66 million people worldwide living with chronic diseases by the year 2050. Therefore, the escalating prevalence of chronic diseases is a key driver for the exosome diagnostics and therapeutics market.
Which Segment Types Are Examined In The Exosome Diagnostic And Therapeutic Market Segment Study?
The exosome diagnostic and therapeutic market covered in this report is segmented –
1) By Product: Instruments, Software, Reagents And Kits
2) By Application: Diagnostics, Therapeutic
3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End Users
Subsegments:
1) By Instruments: Exosome Isolation Systems, Characterization Instruments, Analysis Devices
2) By Software: Data Analysis Software, Exosome Profiling Software
3) By Reagents And KITS: Isolation KITS, Characterization Reagents, Assay KITS
Which Trends Are Influencing Demand In The Exosome Diagnostic And Therapeutic Market?
Leading firms within the exosome diagnostic and therapeutic market are creating advanced offerings, like sample purification systems, aiming to expand their customer reach, boost sales figures, and enhance financial returns. Such a system comprises various procedures and technologies specifically engineered to eliminate unwanted substances and pollutants from a sample, including DNA, RNA, proteins, or other biological molecules. For example, in February 2023, Biological Dynamics Inc., a US-based biotechnology company, introduced ExoVerita, an innovative platform designed for isolating exosomes, intended for applications such as early disease monitoring. The ExoVita Pancreas assay identifies specific exosomal protein markers and has demonstrated efficacy in identifying Stage 1 and Stage 2 pancreatic ductal adenoma carcinoma (PDAC) through blood-derived exosome samples, which are processed on the proprietary ExoVerita device. This validation will enable the company to analyze samples from the ExoLuminate registry trial (NCT05625529), which has begun enrolling patients identified with high-risk PDAC to assess the diagnostic test’s clinical utility. Eligibility also extends to patients exhibiting clinical indicators like pancreatitis or existing pancreatic lesions, individuals with a genetic or familial predisposition, and new diabetes diagnoses in those over 50 years of age.
Which Players Are Part Of The Competitive Landscape Of The Exosome Diagnostic And Therapeutic Market?
Major companies operating in the exosome diagnostic and therapeutic market are Thermo Fisher Scientific Inc., Miltenyi Biotec GmbH, Malvern Instruments Inc., System Biosciences LLC, NanoSomix Inc., Exosome Diagnostics Inc., Evox Therapeutics Ltd., ExCoBio Inc., Codiak BioSciences Inc., Capricor Therapeutics Inc., Aethlon Medical Inc., NX Pharmagen Inc., Aegle Therapeutic Corporation, Ciloa, Sistemic Inc., Theoria Science, Mantra Bio Inc., Lonza Group AG, Bio-Techne Corp.
Get The Full Exosome Diagnostic And Therapeutic Market Report:
Which Region Leads The Exosome Diagnostic And Therapeutic Market In Overall Market Size?
North America was the largest region in the exosome diagnostic and therapeutic market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exosome diagnostic and therapeutic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Exosome Diagnostic And Therapeutic Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=12346&type=smp
Browse Through More Reports Similar to the Global Exosome Diagnostic And Therapeutic Market 2026, By The Business Research Company
Exosome Research Market Report 2026
https://www.thebusinessresearchcompany.com/report/exosome-research-global-market-report
Exosome Technologies Market Report 2026
https://www.thebusinessresearchcompany.com/report/exosome-technologies-global-market-report
Lysosomal Disease Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/lysosomal-disease-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model